ABOS analyst estimates
Acumen Pharmaceuticals (ABOS) analyst ratings, the average price target and its range, and every firm's latest call.
- 2 firms rate ABOS: 1 buy, 1 hold, 0 sell.
- The average price target is $7.00 from None analysts, from $7.00 to $7.00.